Joe Verghese1, Cuiling Wang, Richard B Lipton, Roee Holtzer. 1. Division of Cognitive & Motor Aging, Saul R Korey Department of Neurology, Albert Einstein College of Medicine, 1165 Morris Park Avenue, Rousso 301, Bronx, NY 10461, USA. joe.verghese@einstein.yu.edu
Abstract
BACKGROUND: Despite growing evidence of links between gait and cognition in aging, cognitive risk assessments that incorporate motoric signs have not been examined. We sought to validate a new Motoric Cognitive Risk (MCR) syndrome to identify individuals at high risk of developing dementia. METHODS: We evaluated 997 community residing individuals aged 70 and older participating in the Einstein Aging Study over a median follow-up time of 36.9 months. MCR syndrome was defined as presence of cognitive complaints and slow gait (one standard deviation below age- and sex-specific gait speed means) in nondemented individuals. Cox models were used to evaluate the effect of MCR syndrome on the risk of developing dementia and subtypes. RESULTS: Fifty-two participants met criteria for MCR syndrome at baseline with a prevalence of 7% (95% CI: 5-9%). Prevalence of MCR increased with age. Participants with MCR were at higher risk of developing dementia (hazard ratio [HR] adjusted for age, sex, and education: 3.27, 95% CI: 1.55-6.90) and vascular dementia (adjusted HR: 12.81, 95% CI: 4.98-32.97). The association of MCR with risk of dementia or vascular dementia remained significant even after accounting for other confounders and diagnostic overlap with "cognitive" mild cognitive impairment syndrome subtypes. CONCLUSIONS: A motor-based MCR syndrome provides a clinical approach to identify individuals at high risk for dementia, especially vascular dementia, to target for further investigations and who may benefit from preventive interventions.
BACKGROUND: Despite growing evidence of links between gait and cognition in aging, cognitive risk assessments that incorporate motoric signs have not been examined. We sought to validate a new Motoric Cognitive Risk (MCR) syndrome to identify individuals at high risk of developing dementia. METHODS: We evaluated 997 community residing individuals aged 70 and older participating in the Einstein Aging Study over a median follow-up time of 36.9 months. MCR syndrome was defined as presence of cognitive complaints and slow gait (one standard deviation below age- and sex-specific gait speed means) in nondemented individuals. Cox models were used to evaluate the effect of MCR syndrome on the risk of developing dementia and subtypes. RESULTS: Fifty-two participants met criteria for MCR syndrome at baseline with a prevalence of 7% (95% CI: 5-9%). Prevalence of MCR increased with age. Participants with MCR were at higher risk of developing dementia (hazard ratio [HR] adjusted for age, sex, and education: 3.27, 95% CI: 1.55-6.90) and vascular dementia (adjusted HR: 12.81, 95% CI: 4.98-32.97). The association of MCR with risk of dementia or vascular dementia remained significant even after accounting for other confounders and diagnostic overlap with "cognitive" mild cognitive impairment syndrome subtypes. CONCLUSIONS: A motor-based MCR syndrome provides a clinical approach to identify individuals at high risk for dementia, especially vascular dementia, to target for further investigations and who may benefit from preventive interventions.
Authors: H C Chui; W Mack; J E Jackson; D Mungas; B R Reed; J Tinklenberg; F L Chang; K Skinner; C Tasaki; W J Jagust Journal: Arch Neurol Date: 2000-02
Authors: H A Crystal; D W Dickson; M J Sliwinski; R B Lipton; E Grober; H Marks-Nelson; P Antis Journal: Ann Neurol Date: 1993-10 Impact factor: 10.422
Authors: Joe Verghese; Richard B Lipton; Charles B Hall; Gail Kuslansky; Mindy J Katz; Herman Buschke Journal: N Engl J Med Date: 2002-11-28 Impact factor: 91.245
Authors: Scott Marquis; M Milar Moore; Diane B Howieson; Gary Sexton; Haydeh Payami; Jeffrey A Kaye; Richard Camicioli Journal: Arch Neurol Date: 2002-04
Authors: J C Morris; A Heyman; R C Mohs; J P Hughes; G van Belle; G Fillenbaum; E D Mellits; C Clark Journal: Neurology Date: 1989-09 Impact factor: 9.910
Authors: Joe Verghese; Emmeline Ayers; Nir Barzilai; David A Bennett; Aron S Buchman; Roee Holtzer; Mindy J Katz; Richard B Lipton; Cuiling Wang Journal: Neurology Date: 2014-10-31 Impact factor: 9.910
Authors: Nan Wang; Gilles Allali; Chandrasekharan Kesavadas; Mohan L Noone; Vayyattu G Pradeep; Helena M Blumen; Joe Verghese Journal: J Alzheimers Dis Date: 2016 Impact factor: 4.472
Authors: Olivier Beauchet; Cédric Annweiler; Michele L Callisaya; Anne-Marie De Cock; Jorunn L Helbostad; Reto W Kressig; Velandai Srikanth; Jean-Paul Steinmetz; Helena M Blumen; Joe Verghese; Gilles Allali Journal: J Am Med Dir Assoc Date: 2016-02-04 Impact factor: 4.669
Authors: Ali Ezzati; Andrea R Zammit; Mindy J Katz; Carol A Derby; Molly E Zimmerman; Richard B Lipton Journal: Alzheimer Dis Assoc Disord Date: 2019 Jul-Sep Impact factor: 2.703
Authors: Michelle M Mielke; Rosebud O Roberts; Rodolfo Savica; Ruth Cha; Dina I Drubach; Teresa Christianson; Vernon S Pankratz; Yonas E Geda; Mary M Machulda; Robert J Ivnik; David S Knopman; Bradley F Boeve; Walter A Rocca; Ronald C Petersen Journal: J Gerontol A Biol Sci Med Sci Date: 2012-12-18 Impact factor: 6.053